Data / Drug companies / Northeast Pharma
Northeast Pharma: 7 products in the FDA NDC directory, labeler code 80136
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Northeast Pharma (labeler code 80136) lists 7 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 7 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 26, 2023.
The request: Watch Northeast Pharma (FDA labeler code 80136): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 80136
- Products in commercial distribution
- 7
- Packages
- 8
- Finished drugs by generic name
- 7
- Prescription products
- 0
- Over the counter products
- 7
- Flagged as original packager
- 6 of 6 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 1
- Earliest marketing start
- January 22, 2021
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 3 | 42.9% |
| Over the counter monograph drugs | 2 | 28.6% |
| New drug applications (NDA) | 2 | 28.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 7 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Loperamide hcl | 1 | 42 |
| Diphenhydramine hcl | 1 | 99 |
| Omeprazole | 1 | 106 |
| Loperamide hydrochloride | 1 | 82 |
| Simethicone | 1 | 86 |
| Loperamide hydrochloride and simethicone | 1 | 11 |
| Cetirizine hcl | 1 | 48 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 3 | 42.9% |
| Tablet, delayed release | 1 | 14.3% |
| Capsule, liquid filled | 1 | 14.3% |
| Tablet, chewable | 1 | 14.3% |
| Capsule | 1 | 14.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Cetirizine HCl | 80136-856 | Capsule | New drug applications (NDA) | September 26, 2023 |
| Gas Relief | 80136-859 | Tablet, chewable | Over the counter monograph drugs | June 30, 2023 |
| Loperamide Hydrochloride and Simethicone | 80136-384 | Tablet | Generic drugs (ANDA) | October 27, 2021 |
| Nighttime Sleep-aid | 80136-785 | Tablet | Over the counter monograph drugs | September 1, 2021 |
| Acid Reducer | 80136-852 | Tablet, delayed release | Generic drugs (ANDA) | July 5, 2021 |
| Anti-diarrheal | 80136-851 | Capsule, liquid filled | New drug applications (NDA) | May 21, 2021 |
| Anti-Diarrheal | 80136-063 | Tablet | Generic drugs (ANDA) | January 22, 2021 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.